NO176786C - Fremgangsmåte for fremstilling av lysfölsomme hematoporfyrinforbindelser - Google Patents

Fremgangsmåte for fremstilling av lysfölsomme hematoporfyrinforbindelser

Info

Publication number
NO176786C
NO176786C NO851897A NO851897A NO176786C NO 176786 C NO176786 C NO 176786C NO 851897 A NO851897 A NO 851897A NO 851897 A NO851897 A NO 851897A NO 176786 C NO176786 C NO 176786C
Authority
NO
Norway
Prior art keywords
substances
photosensitizing
light
neoplastic tissue
lasers
Prior art date
Application number
NO851897A
Other languages
English (en)
Other versions
NO176786B (no
NO851897L (no
Inventor
Kenneth R Weishaupt
Thomas J Dougherty
William R Potter
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of NO851897L publication Critical patent/NO851897L/no
Priority to NO941548A priority Critical patent/NO180742C/no
Publication of NO176786B publication Critical patent/NO176786B/no
Publication of NO176786C publication Critical patent/NO176786C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/24—Coupling light guides
    • G02B6/26—Optical coupling means
    • G02B6/262—Optical details of coupling light into, or out of, or between fibre ends, e.g. special fibre end shapes or associated optical elements
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/24—Coupling light guides
    • G02B6/42—Coupling light guides with opto-electronic elements
    • G02B6/4201—Packages, e.g. shape, construction, internal or external details
    • G02B6/4204—Packages, e.g. shape, construction, internal or external details the coupling comprising intermediate optical elements, e.g. lenses, holograms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/24—Coupling light guides
    • G02B6/42—Coupling light guides with opto-electronic elements
    • G02B6/4298—Coupling light guides with opto-electronic elements coupling with non-coherent light sources and/or radiation detectors, e.g. lamps, incandescent bulbs, scintillation chambers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S607/00—Surgery: light, thermal, and electrical application
    • Y10S607/901—Cancer detection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Surgery (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
NO851897A 1982-09-27 1985-05-13 Fremgangsmåte for fremstilling av lysfölsomme hematoporfyrinforbindelser NO176786C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO941548A NO180742C (no) 1982-09-27 1994-04-27 Diagnostisk blanding omfattende porfyrindenderivatkonjugater

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42464782A 1982-09-27 1982-09-27
US06/609,991 US4649151A (en) 1982-09-27 1984-05-14 Drugs comprising porphyrins

Publications (3)

Publication Number Publication Date
NO851897L NO851897L (no) 1985-11-15
NO176786B NO176786B (no) 1995-02-20
NO176786C true NO176786C (no) 1995-07-25

Family

ID=38179904

Family Applications (2)

Application Number Title Priority Date Filing Date
NO851897A NO176786C (no) 1982-09-27 1985-05-13 Fremgangsmåte for fremstilling av lysfölsomme hematoporfyrinforbindelser
NO941548A NO180742C (no) 1982-09-27 1994-04-27 Diagnostisk blanding omfattende porfyrindenderivatkonjugater

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO941548A NO180742C (no) 1982-09-27 1994-04-27 Diagnostisk blanding omfattende porfyrindenderivatkonjugater

Country Status (10)

Country Link
US (8) US4649151A (no)
EP (1) EP0161606B1 (no)
JP (2) JP2532368B2 (no)
CN (1) CN1011571B (no)
AU (1) AU588806B2 (no)
CA (2) CA1265450A (no)
DE (2) DE3587296T2 (no)
DK (1) DK175615B1 (no)
MX (1) MX9203266A (no)
NO (2) NO176786C (no)

Families Citing this family (325)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6603988B2 (en) * 2001-04-13 2003-08-05 Kelsey, Inc. Apparatus and method for delivering ablative laser energy and determining the volume of tumor mass destroyed
US5928222A (en) * 1982-08-06 1999-07-27 Kleinerman; Marcos Y. Fiber optic sensing techniques in laser medicine
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US5456663A (en) * 1984-05-25 1995-10-10 Lemelson; Jerome H. Drugs and methods for treating diseases
US5882330A (en) * 1984-05-25 1999-03-16 Lemelson; Jerome H. Drugs and methods for treating diseases
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US5104637A (en) * 1985-02-06 1992-04-14 University Of Cincinnati Radio labeled dihematophorphyrin ether and its use in detecting and treating neoplastic tissue
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
KR910009202B1 (ko) * 1985-10-23 1991-11-04 니혼메디피직스 가부시끼가이샤 포르피린 유도체의 제조방법
CA1315780C (en) * 1986-01-17 1993-04-06 Yozo Fukuda Porphyrin derivatives
US4667578A (en) * 1986-02-10 1987-05-26 Ford Motor Company Air-extractor casing for motor vehicles
US5948272A (en) * 1986-04-29 1999-09-07 Lemelson; Jerome H. System and method for detecting and neutralizing microorganisms in a fluid using a laser
US5380318A (en) * 1986-05-12 1995-01-10 Surgical Laser Technologies, Inc. Contact or insertion laser probe having wide angle radiation
US4877872A (en) * 1986-06-24 1989-10-31 The University Of Toledo Production and use of dimers of hematoporophyrin, purpurins, chlorines and purpurin- and chlorin-complexes
US4911929A (en) * 1986-08-29 1990-03-27 The United States Of America As Represented By The Secretary Of The Navy Blood substitute comprising liposome-encapsulated hemoglobin
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
JPS63111886A (ja) * 1986-10-29 1988-05-17 呉羽化学工業株式会社 光ダイオ−ドを用いた癌治療装置
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4861876A (en) * 1986-11-26 1989-08-29 Wayne State University Hematoporphyrin derivative and method of preparation and purification
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
DE3750879T2 (de) * 1987-05-26 1995-05-11 Surgical Laser Tech Mit einem breiten Strahlenwinkel versehene Lasersonde für Kontaktierung oder Einfügung.
US4891043A (en) * 1987-05-28 1990-01-02 Board Of Trustees Of The University Of Illinois System for selective release of liposome encapsulated material via laser radiation
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4957481A (en) * 1987-10-01 1990-09-18 U.S. Bioscience Photodynamic therapeutic technique
JPH0629196B2 (ja) * 1987-12-01 1994-04-20 甲子郎 梅村 超音波による腫瘍治療用生理作用増強剤
US5004811A (en) * 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
ATE145337T1 (de) * 1988-05-02 1996-12-15 Phanos Tech Inc Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US5190966A (en) * 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
USRE39094E1 (en) * 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
US5198460A (en) * 1988-07-20 1993-03-30 Health Research Inc. Pyropheophorbides and their use in photodynamic therapy
US4913907A (en) * 1988-08-15 1990-04-03 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US5015478A (en) * 1988-08-15 1991-05-14 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US5091385A (en) * 1988-09-30 1992-02-25 Baylor Research Institute Pre-activated therapeutic agents derived from photoactive compounds
US5177073A (en) * 1988-09-30 1993-01-05 Baylor Research Institute Therapeutic compositions derived from photoactive compounds
JP2729275B2 (ja) * 1988-10-05 1998-03-18 則雄 大工園 レーザ光による加温装置
US5111821A (en) * 1988-11-08 1992-05-12 Health Research, Inc. Fluorometric method for detecting abnormal tissue using dual long-wavelength excitation
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
US4979935A (en) * 1989-02-21 1990-12-25 Quantex Corporation Method of photodynamic therapy employing electron trapping material
US5173504A (en) * 1989-04-21 1992-12-22 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5149708A (en) * 1989-06-07 1992-09-22 University Of British Columbia Photosensitizing Diels-Alder porphyrin derivatives
US5308608A (en) * 1989-06-07 1994-05-03 University Of British Columbia Photosensitizing Diels-Alder porphyrin derivatives
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6710066B2 (en) * 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US20020058008A1 (en) * 1989-07-28 2002-05-16 Kennedy James C. Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
JP2882814B2 (ja) * 1989-08-24 1999-04-12 株式会社エス・エル・ティ・ジャパン レーザ光の照射装置
JP3046315B2 (ja) * 1989-09-05 2000-05-29 株式会社エス・エル・ティ・ジャパン レーザ光の照射装置
EP0416931A3 (en) * 1989-09-07 1993-02-03 Medical Laser Technologies Limited Medical applications for an optical device
JP2882818B2 (ja) * 1989-09-08 1999-04-12 株式会社エス・エル・ティ・ジャパン レーザ光の照射装置
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
CA2075489C (en) * 1990-01-08 2002-01-01 Leroy M. Wood Submersible lens fiberoptic assembly
US5064952A (en) * 1990-01-16 1991-11-12 Board Of Trustees, A Constitutional Corporation Operating Michigan State University Derivatives of porphyrin useful in photodynamic therapy
US5074632A (en) * 1990-03-07 1991-12-24 Health Research, Inc. Fiber optic diffusers and methods for manufacture of the same
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5238940A (en) * 1990-03-22 1993-08-24 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5798238A (en) * 1990-04-16 1998-08-25 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer
US5516629A (en) * 1990-04-16 1996-05-14 Cryopharm Corporation Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US5955256A (en) * 1990-04-16 1999-09-21 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US6251644B1 (en) 1990-04-16 2001-06-26 Baxter International, Inc. Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer
US5071416A (en) * 1990-05-02 1991-12-10 Metalaser Technologies, Inc. Method of and apparatus for laser-assisted therapy
US5169396A (en) * 1990-06-08 1992-12-08 Kambiz Dowlatshahi Method for interstitial laser therapy
US5305759A (en) * 1990-09-26 1994-04-26 Olympus Optical Co., Ltd. Examined body interior information observing apparatus by using photo-pulses controlling gains for depths
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
ZA919934B (en) * 1990-12-20 1992-09-30 Baxter Int Systems and methods for eradicating contaminants using photoactive materials in fluids like blood using discrete sources of radiation
CA2074830C (en) * 1990-12-20 1999-03-02 Daniel F. Bischof Systems and methods for simultaneously removing free and entrained contaminants in fluid like blood using photoactive therapy and cellular separation techniques
JP3051997B2 (ja) * 1990-12-20 2000-06-12 バクスター、インターナショナル、インコーポレイテッド 液体中の汚染物を根絶するシステム及び方法
JP3051996B2 (ja) * 1990-12-20 2000-06-12 バクスター、インターナショナル、インコーポレイテッド 液体中の汚染物を根絶するためのシステム
DE4121876A1 (de) * 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
US5377686A (en) * 1991-10-11 1995-01-03 The University Of Connecticut Apparatus for detecting leakage from vascular tissue
US20040110819A1 (en) * 1991-10-28 2004-06-10 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
DE4136769A1 (de) * 1991-11-05 1993-05-06 Humboldt-Universitaet Zu Berlin, O-1086 Berlin, De Verfahren zum diagnostizieren von mit fluoreszierenden substanzen angereicherten, insbesondere tumoroesen gewebebereichen
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
US5257970A (en) * 1992-04-09 1993-11-02 Health Research, Inc. In situ photodynamic therapy
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
US5575751A (en) * 1992-05-14 1996-11-19 The United States Of America As Represented By The Department Of Health And Human Services Device for measuring incident light in a body cavity
US5505687A (en) * 1992-05-14 1996-04-09 The United States Of America As Represented By The Department Of Health And Human Services Device for measuring incident light in a body cavity
FR2694193B1 (fr) * 1992-07-28 1994-10-28 Abraxas Bio Labs Sa Méthode de cytodiagnostic utilisant l'alstonine comme marqueur sélectif et kit de diagnostic contenant ce marqueur.
US5599924A (en) * 1992-08-14 1997-02-04 Trustees Of The University Of Pennsylvania Electron-deficient porphyrins and processes and intermediates for preparing same
US5298018A (en) * 1992-08-14 1994-03-29 Pdt Cardiovascular, Inc. Method for treating cardiovascular disease through adjunctive photodynamic therapy
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
US5493017A (en) * 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
FI950730L (fi) * 1992-08-17 1995-04-10 Quadra Logic Tech Inc Menetelmä ei-toivottujen solujen tai kudosten kasvun tuhoamiseksi tai ehkäisemiseksi
PL308116A1 (en) * 1992-09-21 1995-07-24 Quadra Logic Technologies Percutaneous in vivo activation of a photosensitive factor present in blood
US5286474A (en) * 1992-10-22 1994-02-15 Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf The Arizona State University Use of carotenoporphyrins as tumor localizing agents for diagnosis
US5303324A (en) * 1992-10-29 1994-04-12 American Cyanamid Company Method and apparatus for providing controlled light distribution from a cylindrical fiberoptic diffuser
WO1994012239A1 (en) * 1992-11-20 1994-06-09 University Of British Columbia Method of activating photosensitive agents
US6214033B1 (en) 1992-12-28 2001-04-10 Matsushita Electric Industrial Co., Ltd. Medical laser apparatus and diagnostic/treatment apparatus using the medical laser apparatus
JP2596221B2 (ja) * 1992-12-28 1997-04-02 松下電器産業株式会社 医療用レーザ装置および診断・治療装置
US5614502A (en) * 1993-01-15 1997-03-25 The General Hospital Corporation High-pressure impulse transient drug delivery for the treatment of proliferative diseases
US5658892A (en) * 1993-01-15 1997-08-19 The General Hospital Corporation Compound delivery using high-pressure impulse transients
US5437274A (en) * 1993-02-25 1995-08-01 Gholam A. Peyman Method of visualizing submicron-size vesicles and particles in blood circulation
JP3565442B2 (ja) * 1993-04-22 2004-09-15 新日本石油化学株式会社 哺乳類の関節炎の診断剤および／または治療剤
US5539100A (en) * 1993-07-01 1996-07-23 The United States Of America As Represented By The United States Department Of Energy Organic solid state switches incorporating porphyrin compounds and method for producing organic solid state optical switches
US5445608A (en) * 1993-08-16 1995-08-29 James C. Chen Method and apparatus for providing light-activated therapy
US5441531A (en) * 1993-10-18 1995-08-15 Dusa Pharmaceuticals Inc. Illuminator and methods for photodynamic therapy
US5474528A (en) * 1994-03-21 1995-12-12 Dusa Pharmaceuticals, Inc. Combination controller and patch for the photodynamic therapy of dermal lesion
US6231593B1 (en) * 1994-03-21 2001-05-15 Dusa Pharmaceuticals, Inc. Patch, controller, and method for the photodynamic therapy of a dermal lesion
DE69514262T2 (de) * 1994-03-23 2001-10-11 Hamamatsu Photonics K.K., Hamamatsu Katheter mit Lichtleitfaser
US5588962A (en) * 1994-03-29 1996-12-31 Boston Scientific Corporation Drug treatment of diseased sites deep within the body
US5519534A (en) * 1994-05-25 1996-05-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Irradiance attachment for an optical fiber to provide a uniform level of illumination across a plane
US7255851B2 (en) * 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
JP2943094B2 (ja) * 1994-08-03 1999-08-30 日本ワイスレダリー株式会社 光ファイバレーザデバイス
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
CA2199864C (en) 1994-09-16 2006-06-20 Seth A. Foerster Methods and devices for defining and marking tissue
US5490840A (en) * 1994-09-26 1996-02-13 General Electric Company Targeted thermal release of drug-polymer conjugates
US5527704A (en) 1994-12-06 1996-06-18 Baxter International Inc. Apparatus and method for inactivating viral contaminants in body fluids
US5660181A (en) * 1994-12-12 1997-08-26 Physical Optics Corporation Hybrid neural network and multiple fiber probe for in-depth 3-D mapping
US5935942A (en) * 1994-12-14 1999-08-10 Zeimer; Ran Selective and non-invasive visualization or treatment of vasculature
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
US5728090A (en) * 1995-02-09 1998-03-17 Quantum Devices, Inc. Apparatus for irradiating living cells
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
US6316007B1 (en) * 1995-04-04 2001-11-13 Wound Healing Of Oklahoma Combined physical and immunotherapy for cancer
CA2215978A1 (en) * 1995-04-04 1996-10-10 Wound Healing Of Oklahoma Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
US6235508B1 (en) 1995-06-07 2001-05-22 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
AT403990B (de) * 1995-11-24 1998-07-27 Nagypal Tibor Dipl Ing Dr Gerät zur photodynamischen behandlung von lebewesen bzw. organen derselben
ATE243513T1 (de) * 1996-05-01 2003-07-15 Gen Hospital Corp Wachstumshemmung und abtoetung solider tumore unter verwendung eines prolaktin-modulators und eines photosensitizers
US5814008A (en) * 1996-07-29 1998-09-29 Light Sciences Limited Partnership Method and device for applying hyperthermia to enhance drug perfusion and efficacy of subsequent light therapy
EP1552794B1 (en) 1996-08-12 2009-05-06 Ethicon Endo-Surgery, Inc. Apparatus for marking tissue
US5902310A (en) * 1996-08-12 1999-05-11 Ethicon Endo-Surgery, Inc. Apparatus and method for marking tissue
EP1284123B1 (en) 1996-08-12 2005-07-20 Ethicon Endo-Surgery, Inc. Apparatus for marking tissue
US5846834A (en) * 1996-12-31 1998-12-08 Ronn; Avigdor M. Method for assaying photosensitizing drug in whole blood
US5843790A (en) * 1996-12-31 1998-12-01 Ronn; Avigdor M. Method for assaying photosensitizing drug in whole blood
US6107101A (en) * 1996-12-31 2000-08-22 Ronn; Avigdor M. Method for assaying photosensitizing drug in tissue
US5882940A (en) * 1996-12-31 1999-03-16 Ronn; Avigdor M. Method for assaying photosensitizing drug in plasma
US5845640A (en) * 1997-01-24 1998-12-08 Spectra Science Corporation Chemiluminescent sources for photodynamic therapy and photomedicine
US6274614B1 (en) 1997-02-11 2001-08-14 Qlt Inc. Methods, compositions and articles for reducing or preventing the effects of inflammation
EP0996465B1 (en) 1997-02-11 2004-06-30 QLT Inc. Compositions and articles for reducing the effects of inflammation
JPH10279502A (ja) * 1997-03-31 1998-10-20 Katsuro Tachibana 光感受性物質の励起方法
FR2764812B1 (fr) * 1997-06-23 1999-10-08 Lasertec International Installation de traitement des cellules malades d'un tissu vivant pour les eliminer
US6233481B1 (en) 1997-10-09 2001-05-15 Spectra Science Corporation Diagnostic application of sono-chemical excitation of fluorescent photosensitizers
US6103751A (en) * 1998-06-22 2000-08-15 Health Research, Inc. Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents
US6261302B1 (en) 1998-06-26 2001-07-17 Ethicon Endo-Surgery, Inc. Applier for implantable surgical marker
US5941890A (en) * 1998-06-26 1999-08-24 Ethicon Endo-Surgery, Inc. Implantable surgical marker
US7049110B2 (en) * 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US6117862A (en) * 1998-10-09 2000-09-12 Qlt, Inc. Model and method for angiogenesis inhibition
US6511971B1 (en) 1998-10-13 2003-01-28 Brown University Research Foundation Substituted perhalogenated phthalocyanines
US6220248B1 (en) 1998-10-21 2001-04-24 Ethicon Endo-Surgery, Inc. Method for implanting a biopsy marker
EA003414B1 (ru) * 1998-10-23 2003-04-24 Майкл Иссачарофф Устройство для нейро-иммуно-эндокринной регуляции и лечения
US6083237A (en) * 1998-10-23 2000-07-04 Ethico Endo-Surgery, Inc. Biopsy instrument with tissue penetrating spiral
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
US6936044B2 (en) * 1998-11-30 2005-08-30 Light Bioscience, Llc Method and apparatus for the stimulation of hair growth
US6283956B1 (en) * 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US6887260B1 (en) * 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US20060212025A1 (en) * 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
JP2002534483A (ja) * 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 代謝性骨障害または骨転移のための治療的組成物
WO2000041726A2 (en) 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
SE517478C2 (sv) * 1999-04-30 2002-06-11 Valinge Aluminium Ab Låssystem för mekanisk hofogning av golvskivor, golvskiva försedd med låssystemet samt metod för framställning av mekaniskt hopfogningsbara golvskivor
US7022843B1 (en) 1999-04-14 2006-04-04 The University Of British Columbia β,β′-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US20020058028A1 (en) * 1999-05-05 2002-05-16 Mark K. Malmros Method of in situ diagnosis by spectroscopic analysis of biological stain compositions
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
US20040228871A1 (en) * 1999-06-03 2004-11-18 Tayyaba Hasan Treatment and analysis of proliferative disorders
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7078014B2 (en) * 1999-12-23 2006-07-18 Health Research, Inc. Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US6534040B2 (en) 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7097826B2 (en) * 1999-12-23 2006-08-29 Health Research, Inc. Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US20020049247A1 (en) * 2000-01-12 2002-04-25 Chen James C. Novel treatment for eye disease
US6448030B1 (en) * 2000-02-18 2002-09-10 University Of Nevada-Las Vegas Method for predicting the efficacy of anti-cancer drugs
US6794505B1 (en) * 2000-03-30 2004-09-21 Miravant Pharmaceuticals, Inc. Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
US6503268B1 (en) * 2000-04-03 2003-01-07 Ceramoptec Industries, Inc. Therapeutic laser system operating between 1000nm and 1300nm and its use
US6425903B1 (en) 2000-05-09 2002-07-30 James W. Voegele Implantable surgical marker
US7648699B2 (en) * 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) * 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) * 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
WO2002008230A1 (en) * 2000-07-21 2002-01-31 North Carolina State University Trans beta substituted chlorins and methods of making and using the same
US6765092B2 (en) * 2000-07-21 2004-07-20 North Carolina State University Regioisomerically pure oxochlorins and methods of synthesis
US6559374B2 (en) * 2000-07-21 2003-05-06 North Carolina State University Trans beta substituted chlorins and methods of making and using the same
EP1339862B1 (en) 2000-11-29 2014-01-08 PCI Biotech AS Photochemical internalization for virus-mediated molecule delivery into the cytosol
PT1346059E (pt) 2000-11-29 2012-06-01 Pci Biotech As Internalização fotoquímica para distribuição de moléculas no citosol
US6462192B2 (en) 2001-01-23 2002-10-08 Miravant Pharmaceuticals, Inc. Processes for large scale production of tetrapyrroles
WO2002064163A2 (en) 2001-02-15 2002-08-22 Qlt Inc. Reduction or prevention of pdt related inflammation
US6495585B2 (en) * 2001-03-07 2002-12-17 Health Research, Inc. Method for treating hyperproliferative tissue in a mammal
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US6946552B2 (en) * 2001-05-10 2005-09-20 North Carolina State University Refined routes to chlorin building blocks
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US6796710B2 (en) * 2001-06-08 2004-09-28 Ethicon Endo-Surgery, Inc. System and method of measuring and controlling temperature of optical fiber tip in a laser system
US6858114B2 (en) 2001-07-03 2005-02-22 The University Of Alabama Laser hydrolysis of polypeptides
US6849730B2 (en) 2001-09-25 2005-02-01 North Carolina State University Methods of making porphyrins and related compounds with Lewis acids
EP1467760A2 (en) * 2002-01-23 2004-10-20 Light Sciences Corporation Systems and methods for photodynamic therapy
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
NZ534912A (en) * 2002-02-04 2007-08-31 Alfama Investigacao E Desenvol supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
US6913615B2 (en) * 2002-03-25 2005-07-05 Lumerx, Inc. Chemiluminescent treatment of acne
WO2003084601A2 (en) * 2002-04-02 2003-10-16 Lumerx, Inc. Apparatus and methods using visible light for debilitating and/or killing microorganisms within the body
US9440046B2 (en) 2002-04-04 2016-09-13 Angiodynamics, Inc. Venous insufficiency treatment method
US7056318B2 (en) * 2002-04-12 2006-06-06 Reliant Technologies, Inc. Temperature controlled heating device and method to heat a selected area of a biological body
AU2003223613A1 (en) * 2002-04-16 2003-11-03 Lumerx, Inc Chemiluminescent light source using visible light for biotherapy
US7175611B2 (en) 2002-06-05 2007-02-13 Mark Alan Mitchnick Antimicrobial release system
AU2003249742A1 (en) * 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
US7201766B2 (en) * 2002-07-03 2007-04-10 Life Support Technologies, Inc. Methods and apparatus for light therapy
WO2008124790A2 (en) 2002-07-10 2008-10-16 Angiodynamics, Inc. Device and method for endovascular treatment for causing closure of a blood vessel
WO2004012805A2 (en) * 2002-08-05 2004-02-12 Miravant Medical Technologies Light delivery catheter
EP1526801A2 (en) * 2002-08-05 2005-05-04 Miravant Medical Technologies Inc. Catheter for diagnosis and treatment of diseased vessels
US8123698B2 (en) * 2002-10-07 2012-02-28 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
JP2006522660A (ja) * 2003-04-10 2006-10-05 ライト バイオサイエンス，エルエルシー 細胞増殖及び遺伝子発現を調節するためのフォトモジュレーション方法及び装置
US7884280B2 (en) * 2003-05-27 2011-02-08 North Carolina State University Stepwise fabrication of molecular-based, cross linked, light harvesting arrays
US20060282132A1 (en) * 2003-06-20 2006-12-14 Keio University Photodynamic therapy equipment, method for controlling photodynamic therapy equipment and method of photodynamic method
US7057100B2 (en) * 2003-06-26 2006-06-06 The J.C. Robinson Seed Co. Inbred corn line W23129
US8251057B2 (en) 2003-06-30 2012-08-28 Life Support Technologies, Inc. Hyperbaric chamber control and/or monitoring system and methods for using the same
US20050015123A1 (en) * 2003-06-30 2005-01-20 Paithankar Dilip Y. Endovascular treatment of a blood vessel using a light source
ES2572976T3 (es) * 2003-07-31 2016-06-03 Gentlewaves Llc Sistema y método para el tratamiento fotodinámico de la piel
US20050049508A1 (en) * 2003-08-06 2005-03-03 Michael Forman Treatment of age-related macular degeneration
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US20120289859A9 (en) * 2003-08-27 2012-11-15 Nicoson Zachary R System and method for minimally invasive disease therapy
US8172770B2 (en) * 2005-09-28 2012-05-08 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
US20050065436A1 (en) * 2003-09-23 2005-03-24 Ho Winston Zonh Rapid and non-invasive optical detection of internal bleeding
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
DE602005011928D1 (de) 2004-01-20 2009-02-05 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
US7167078B2 (en) * 2004-02-19 2007-01-23 Pourchot Shawn C Electric, telephone or network access control system and method
US20050234336A1 (en) * 2004-03-26 2005-10-20 Beckman Andrew T Apparatus and method for marking tissue
US20050240073A1 (en) * 2004-04-26 2005-10-27 Apffelstaedt Justus P Devices and methods to conform and treat body cavities
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US20050244458A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US20050244466A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Photodynamic therapy in conjunction with intraocular implants
US8673341B2 (en) * 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
US20050244471A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
WO2005110374A1 (en) * 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US8591885B2 (en) * 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8455656B2 (en) 2004-04-30 2013-06-04 Allergan, Inc. Kinase inhibitors
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US20050244500A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intravitreal implants in conjuction with photodynamic therapy to improve vision
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US20050244462A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Devices and methods for treating a mammalian eye
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
WO2005107708A1 (en) 2004-04-30 2005-11-17 Allergan, Inc. Biodegradable intravitreal tyrosine kinase inhibitors implants
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
US20050244461A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Controlled release drug delivery systems and methods for treatment of an eye
US7708751B2 (en) 2004-05-21 2010-05-04 Ethicon Endo-Surgery, Inc. MRI biopsy device
US8932233B2 (en) 2004-05-21 2015-01-13 Devicor Medical Products, Inc. MRI biopsy device
US9638770B2 (en) 2004-05-21 2017-05-02 Devicor Medical Products, Inc. MRI biopsy apparatus incorporating an imageable penetrating portion
US7761945B2 (en) 2004-05-28 2010-07-27 Life Support Technologies, Inc. Apparatus and methods for preventing pressure ulcers in bedfast patients
DE102004030391A1 (de) * 2004-06-23 2006-01-26 Somatex Medical Technologies Gmbh Marker
WO2006017347A2 (en) * 2004-07-12 2006-02-16 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
KR100604350B1 (ko) * 2004-07-15 2006-07-25 학교법인 인제학원 광역학 치료용 광민감성 물질로 유용한 사이클릭테트라피롤 고분자와 이의 제조방법
US7947729B2 (en) * 2004-07-16 2011-05-24 Health Research, Inc. Adduct of fluorescent dye and tumor avid tetrapyrrole
WO2006020979A2 (en) * 2004-08-13 2006-02-23 Yale University Factor vii conjugates for selectively treating neovascularization disorders
WO2006036176A1 (en) * 2004-09-24 2006-04-06 Light Sciences Corporation Extended treatment of tumors through vessel occlusion with light activated drugs
US20060084951A1 (en) * 2004-10-05 2006-04-20 Heacock Gregory L Low energy of excitation PDT compounds for treatment of ocular disease
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US7323561B2 (en) * 2004-12-23 2008-01-29 North Carolina State University Metal complexation of 1-acyldipyrromethanes and porphyrins formed therefrom
US20060223750A1 (en) * 2005-04-01 2006-10-05 Allergan, Inc. Agents and methods for enhancing photodynamic therapy
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US20070005071A1 (en) * 2005-06-30 2007-01-04 Cannuflow, Inc. System and method for locating resorbable tissue fixation devices
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
US20080200834A1 (en) * 2005-09-28 2008-08-21 Mark Joseph L Introducer device for improved imaging
US20070168000A1 (en) * 2006-01-13 2007-07-19 Happawana Gemunu S Apparatus and method for cooling lasers using insulator fluid
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US7657147B2 (en) * 2006-03-02 2010-02-02 Solar Light Company, Inc. Sunlight simulator apparatus
KR100794555B1 (ko) * 2006-08-10 2008-01-17 한국전기연구원 다중 파장 광원 장치 및 이를 이용한 생체 조직의 광학특성 분석 시스템
DE602007010660D1 (de) * 2006-10-11 2010-12-30 Light Sciences Oncology Inc Lichtabgabesystem
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
KR100808630B1 (ko) * 2006-12-28 2008-02-29 광주과학기술원 클로린 화합물을 포함하는 경구투여용 항종양 조성물
US20090162423A1 (en) * 2007-12-20 2009-06-25 Ceramoptec Industries, Inc. Formulations for cosmetic and wound care treatments with photosensitizes as fluorescent markers
EP2131773B1 (en) 2007-02-05 2011-11-23 Novian Health Inc. Interstitial laser therapy kits and interstitial laser therapy control system
US8092507B2 (en) 2007-02-05 2012-01-10 Novian Health, Inc. Interstitial energy treatment probe holders
US7911053B2 (en) * 2007-04-19 2011-03-22 Marvell World Trade Ltd. Semiconductor packaging with internal wiring bus
JP2010535235A (ja) * 2007-08-01 2010-11-18 カリディアンビーシーティ バイオテクノロジーズ，エルエルシー 全血の病原性不活性化
WO2009026073A1 (en) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prevention of transfusion related acute lung injury using riboflavin and light
CN101848668A (zh) * 2007-09-14 2010-09-29 健康研究有限公司 用于肿瘤显像和治疗的多模态试剂
US20100056983A1 (en) * 2007-09-27 2010-03-04 Health Research, Inc. Treatment of cancer using photodynamic therapy
US8202229B2 (en) 2007-10-01 2012-06-19 Suros Surgical Systems, Inc. Surgical device
JP5127605B2 (ja) * 2008-07-07 2013-01-23 富士フイルム株式会社 光断層画像化装置
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
DK2498783T3 (en) 2009-11-09 2018-12-10 Allergan Inc COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
EP2526103B1 (en) 2010-01-22 2016-05-04 Council of Scientific & Industrial Research A process for the preparation of novel porphyrin derivatives and their use as pdt agents and fluorescence probes
US8609837B2 (en) 2010-07-06 2013-12-17 Health Research, Inc. Metallation enhancements in tumor-imaging and PDT therapy
WO2012114333A1 (en) 2011-02-24 2012-08-30 Ilan Ben Oren Hybrid catheter for vascular intervention
EP2699242B1 (en) 2011-04-19 2017-11-01 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US8992513B2 (en) 2011-06-30 2015-03-31 Angiodynamics, Inc Endovascular plasma treatment device and method of use
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
US20130123648A1 (en) * 2011-11-11 2013-05-16 Leontios Stampoulidis Medical diagnosis and treatment using multi-core optical fibers
WO2013078235A1 (en) * 2011-11-23 2013-05-30 Broncus Medical Inc Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US20140066819A1 (en) * 2012-04-13 2014-03-06 Bruker Biospin Corporation Luminescence-guided focused ultrasound apparatus and method
US12514456B2 (en) 2013-01-31 2026-01-06 Eximo Medical Ltd. System and methods for lesion characterization in blood vessels
EP2956096A1 (en) 2013-02-15 2015-12-23 Allergan, Inc. Sustained drug delivery implant
USD733873S1 (en) 2013-05-07 2015-07-07 Novian Health Inc. Probe holder
US10035806B2 (en) 2015-10-06 2018-07-31 California Institute Of Technology Derivatized corroles and metallocorroles and their use as imaging and therapeutic agents
US11684420B2 (en) 2016-05-05 2023-06-27 Eximo Medical Ltd. Apparatus and methods for resecting and/or ablating an undesired tissue
EP3471774A4 (en) 2016-06-16 2020-04-15 Oncoselect Therapeutics, LLC PORPHYRINE COMPOUNDS AND COMPOSITIONS FOR TREATING CANCER
WO2018170134A1 (en) 2017-03-14 2018-09-20 Ohio State Innovation Foundation Methods and compositions related to a tissue factor-targeting igg3 immunoconjugates
US11285335B2 (en) 2018-10-08 2022-03-29 Biohacked, Inc. Photo-therapeutic method and apparatus
US12376904B1 (en) 2020-09-08 2025-08-05 Angiodynamics, Inc. Dynamic laser stabilization and calibration system
US12311195B2 (en) * 2021-08-03 2025-05-27 Modulight Corporation Theranostic laser system
US12038322B2 (en) 2022-06-21 2024-07-16 Eximo Medical Ltd. Devices and methods for testing ablation systems

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814081A (en) * 1971-04-02 1974-06-04 Olympus Optical Co Optical measuring catheter
DE2308252A1 (de) * 1973-02-20 1974-08-22 Basf Ag Verfahren zur herstellung von mesotetraarylporphinen
GB1485908A (en) * 1974-05-21 1977-09-14 Nath G Apparatus for applying light radiation
JPS53109929A (en) * 1977-03-04 1978-09-26 Nippon Oil Co Ltd Medicin for malignant tumor
JPS5587793A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Carcinostatic meso-tetra(p-carboxyphenyl)porphine derivative
US4336809A (en) * 1980-03-17 1982-06-29 Burleigh Instruments, Inc. Human and animal tissue photoradiation system and method
JPS58155852A (ja) * 1982-03-10 1983-09-16 株式会社東芝 レ−ザ治療装置
US4485820A (en) * 1982-05-10 1984-12-04 The Johns Hopkins University Method and apparatus for the continuous monitoring of hemoglobin saturation in the blood of premature infants
JPS5944274A (ja) * 1982-09-03 1984-03-12 株式会社東芝 レ−ザ治療装置
DE3323365C2 (de) * 1982-09-04 1994-10-20 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zur Ausleuchtung von Hohlräumen
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
AU581840B2 (en) * 1982-09-27 1989-03-09 Health Research Inc. Porphyrin derivatives
JPS60126291A (ja) * 1983-03-14 1985-07-05 Koichi Shiyudo ポルフイリン誘導体
DE3464252D1 (en) * 1983-06-03 1987-07-23 Hoffmann La Roche Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
JPS6092287A (ja) * 1983-10-24 1985-05-23 Toyo Hatsuka Kogyo Kk ９−デスオキソ−９−ハイドロオキシ−フエオホ−バイド誘導体およびそれらのアルカリ塩類
JPS60152487A (ja) * 1984-01-18 1985-08-10 Sato Yakugaku Kenkyusho:Kk デユウテロポルフイリン誘導体及びその塩
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
FR2620938B3 (fr) * 1987-09-30 1990-01-05 Bontemps Raymond Nouveau dispositif destine a conserver des substances cosmetiques congelables

Also Published As

Publication number Publication date
NO941548D0 (no) 1994-04-27
NO941548L (no) 1985-11-15
JP2532368B2 (ja) 1996-09-11
JPH06105921A (ja) 1994-04-19
US4932934A (en) 1990-06-12
NO180742C (no) 1997-06-11
EP0161606B1 (en) 1993-04-28
US4866168A (en) 1989-09-12
US5015463A (en) 1991-05-14
DK210185A (da) 1985-11-15
CN85103992A (zh) 1986-11-19
US4889129A (en) 1989-12-26
CA1265450A (en) 1990-02-06
DE161606T1 (de) 1986-06-12
DE3587296T2 (de) 1993-11-18
NO176786B (no) 1995-02-20
CA1275452C (en) 1990-10-23
JPS6113A (ja) 1986-01-06
JPH084631B2 (ja) 1996-01-24
US4649151A (en) 1987-03-10
EP0161606A2 (en) 1985-11-21
US5145863A (en) 1992-09-08
US5225433A (en) 1993-07-06
EP0161606A3 (en) 1990-01-10
NO851897L (no) 1985-11-15
NO180742B (no) 1997-03-03
AU588806B2 (en) 1989-09-28
AU4246185A (en) 1985-11-21
DK175615B1 (da) 2004-12-27
US5028621A (en) 1991-07-02
DK210185D0 (da) 1985-05-10
MX9203266A (es) 1992-07-01
CN1011571B (zh) 1991-02-13
DE3587296D1 (de) 1993-06-03

Similar Documents

Publication Publication Date Title
NO176786C (no) Fremgangsmåte for fremstilling av lysfölsomme hematoporfyrinforbindelser
CA1314942C (en) Apparatus for treatment of cancer with photodiode
Reddi et al. Flash photolysis studies of hemato‐and copro‐porphyrins in homogeneous and microheterogeneous aqueous dispersions
US5257970A (en) In situ photodynamic therapy
US4925736A (en) Topical hematoporphyrin
Kessel Photosensitization with derivatives of haematoporphyrin
NO166284C (no) Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer.
LU90718I2 (fr) Visudyne-verteporfin et ses d-riv-s pharmaceutiquement acceptables
JPH08231428A (ja) 表在局所的医薬組成物
ES2165391T3 (es) Esteres del acido metilfosfonico, procedimiento para su preparacion y su empleo.
KR840003415A (ko) 경구용 당뇨병 치료제의 제조방법
US20050177207A1 (en) Synergism of photodynamic and electropermeation effect on cell vitality as a novel cytotoxic agent
Edell et al. Combined effects of hematoporphyrin derivative phototherapy and adriamycin in a murine tumor model
NO900342D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-5,6-dihydrobenz(c)acridin-7-carboxylsyrer og beslektede forbindelser.
EP0330625B1 (en) Total synthesis method for making an indole structure derivative product class, of the triptamine type, in particular, melatonin or N-acetyl-5-methoxytriptamine type, having a high purity degree and easily soluble, for therapeutic use against acquired immuno-deficiency syndromes
ES2042529T3 (es) Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa.
NO179196B (no) Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on
JP2004512270A (ja) ジヒドロポルフィリンの誘導体とその使用
RU2019180C1 (ru) Средство для лечения подкожной фибросаркомы и способ его получения
EP0086453A3 (en) Thiazaspiro derivatives, process for their preparation and pharmaceutical composition
Lane et al. Comparative study of the surgical application of holmium and CO2 lasers
MY101266A (en) Pharmaceutical formulations
CA1265450C (en) PHARMACEUTICAL PRODUCT, ITS PREPARATION, AND ITS USE FOR THE TREATMENT OF TUMORS
JPS54128482A (en) Microcapsule and its preparation
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
MK1K Patent expired